Prevention of cerebral edema by the vasopressin antagonist d(CH2)5D-Ile2Ile4Ala9AVP in rats with experimental subarachnoid hemorrhage.
László
F A
FA
Department of Comparative Physiology, Attila József University of Sciences, Szeged, Hungary.
Varga
C
C
Baláspiri
L
L
D000818:Animals; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology; D001834:Body Water / Q000378:metabolism; D001921:Brain / Q000378:metabolism; D001929:Brain Edema / Q000209:etiology / Q000517:prevention & control*; D004573:Electrolytes / Q000378:metabolism; D007177:Inappropriate ADH Syndrome / Q000517:prevention & control; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D013345:Subarachnoid Hemorrhage / Q000150:complications* / Q000378:metabolism; D014667:Vasopressins / Q000037:antagonists & inhibitors*
D004573:Electrolytes; C070737:argipressin, beta mercapto(beta,beta)-cyclopentamethylenepropionic acid(1)-Ile(2,4)-Ala-NH2(9)-; D014667:Vasopressins; D001127:Arginine Vasopressin